Phagenesis Limited
USPTO PatentsView assignee record - 11 granted patents across 10 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).
The verdict
According to USPTO PatentsView, Phagenesis ranks #24,991 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 10 technology areas.
- #24,991
- of 49,997 US assignees by volume
- Top 49%
- by Innovation Score (35.4/100)
- 14.9
- avg claims per patent
- +600%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R24991 · Foreign Corporation #24,991 · 11 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 11 grants
- MID-PACK #24,991/49,997
- PHOTO-FINISH PerceptiMed
- CPC-FOCUS A61M · 10 areas
- INNOV-THIN 35.4/100
- CLAIMS-RICH 14.9 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +600% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: PerceptiMed, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Phagenesis’s 35.4 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Phagenesis
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Phagenesis · this assignee
Phagenesis · this assignee
35 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Phagenesis's Innovation Score is 35.4/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Phagenesis?
Each dot is one of Phagenesis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Phagenesis’s own 14.9 claims/patent is at or below the 18.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Phagenesis's grants concentrate
Phagenesis Limited is a focused PatentsView assignee: 10 CPC subclasses with 72.7% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2024 (3 grants) versus a trough of 1 in 2019. By volume, Phagenesis sits between PerceptiMed, Inc. and Phononic Devices, Inc..
Phagenesis's three-year grant acceleration
Phagenesis Limited shows 4 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Phagenesis's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Perceptimed
PerceptiMed, Inc.
11 patents
- Percutaneous Card…
Percutaneous Cardiovascular Solutions Pty Ltd
11 patents
- Pericom Semicondu…
Pericom Semiconductor Corporation
11 patents
- Peter Maccallum C…
Peter MacCallum Cancer Institute
11 patents
- Pham Holdings
Pham Holdings, Inc.
11 patents
- Philter Labs Inco…
Philter Labs Incorporated
11 patents
- Phoenix
Phoenix Technologies Ltd.
11 patents
- Phononic Devices
Phononic Devices, Inc.
11 patents
- Phagenesis ◀
Phagenesis Limited
11 patents
What this shows Phagenesis holds 11 patents at rank #24,997, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Phagenesis
By rank, the assignees closest to #24,997 in granted patent volume.
- PerceptiMed, Inc. #24,993 · 11 patents
- Percutaneous Cardiovascular Solutions Pty Ltd #24,994 · 11 patents
- Pericom Semiconductor Corporation #24,995 · 11 patents
- Peter MacCallum Cancer Institute #24,996 · 11 patents
- Pham Holdings, Inc. #24,998 · 11 patents
- Philter Labs Incorporated #24,999 · 11 patents
- Phoenix Technologies Ltd. #25,000 · 11 patents
- Phononic Devices, Inc. #25,001 · 11 patents
Leaders in A61M (Devices FOR Introducing Media Into)
Other assignees with the most granted patents in Phagenesis's primary technology class.
- Becton, Dickinson and Company 1,249 in class
- Sanofi-Aventis Deutschland GMBH 1,159 in class
- Boston Scientific Scimed, Inc. 901 in class
- Koniniklijke Philips N.V. 836 in class
- Fisher & Paykel Healthcare Limited 773 in class
- Covidien LP 726 in class
- Terumo Kabushiki Kaisha 724 in class
- ResMed Pty Ltd 682 in class
Phagenesis's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
35 Top 49% higher than 51% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 1 | 9.1% |
| 2020 | 2 | 18.2% |
| 2021 | 1 | 9.1% |
| 2023 | 1 | 9.1% |
| 2024 | 3 | 27.3% |
| 2025partial year | 3 | 27.3% |
Which technologies does Phagenesis Limited patent most?
Top 10 of 10 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Phagenesis Limited's patent record in context - here's where to go next.
- Phagenesis Limited's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 72.7% of its portfolio - see every assignee active in that class. Explore A61M
- Ranked #24,991 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Phagenesis Limited against PerceptiMed, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 35.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.